References
- Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). Official Journal of the European Communities L34 2001;45:13–6.
- European Surveillance of Antimicrobial Consumption. ESAC – Final scientific report. ESAC; 2007.
- World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway: WHO; 2013. Available at: http://www.whocc.no/ (accessed 12 May 2013).
- Lyfjastofum. Icelandic Medicines Agency. Available at: http://www.lyfjastofnun.is (accessed 1 December 2011).
- NOMESCO. Medicines Consumption in the Nordic Countries 2004–2008. NOMESCO; . Available at: http://nomesco-eng.nom-nos.dk/filer/publikationer/Medicines%20consumption%202004-2008%20web.pdf (accessed 11 July 2012).
- Danish Medicines Agency. Medicine sales in Denmark. Danish Medicines Agency; Available at: http://www.medstat.dk (accessed 1 December 2011).
- DANMAP. DANMAP 2010—Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. DANMAP; 2010.
- Coenen S, Adriaenssens N, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997–2009). J Antimicrob Chemother 2011;66(Suppl 6):vi57–70.
- DANMAP. DANMAP 2012—Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. DANMAP; 2012 p 58.
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother 2011; 66(Suppl 6):vi3–12.
- Hjálmarsdóttir MA, Kristinsson KG. Epidemiology of penicillin-non-susceptible pneumococci in Iceland, 1995–2010. J Antimicrob Chemother 2014;69:940–6.
- Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997–2009). J Antimicrob Chemother 2011; 66(Suppl 6):vi13–23.
- Rasmussen J, Nielsen OW, Lund AM, Køber L, Djurhuus H. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J Inherit Metab Dis 2013;36:35–41.
- Schwartson R. Landsapotekarin, Kunningarskriv til tannlæknar. Tórshavn; 2012.
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009). J Antimicrob Chemother 2011;66(Suppl 6): vi37–45.
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009). J Antimicrob Chemother 2011; 66(Suppl 6):vi47–56.
- ESAC. European Surveillance of Antimicrobial Consumption. Final management report 2009–2010. ESAC; 2010. Available at: http://www.esac.ua.ac.be/main.aspx?c = *ESAC2&n = 50006 (accessed 5 January 2012).
- DANMAP. DANMAP 2008—Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. DANMAP; 2008.